Tue, March 5, 2024

David Amsellem Maintained (AVDL) at Buy with Increased Target to $23 on, Mar 5th, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-23-on-mar-5th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
David Amsellem of Piper Sandler, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $18 to $23 on, Mar 5th, 2024.

David has made no other calls on AVDL in the last 4 months.



There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $21 on, Tuesday, February 6th, 2024